US Stock MarketDetailed Quotes
CYCN Cyclerion Therapeutics
- 2.8200
- -0.2200-7.24%
Close May 2 16:00 ET
7.64MMarket Cap-1253P/E (TTM)
3.0000High2.8000Low2.32KVolume3.0000Open3.0400Pre Close6.71KTurnover0.18%Turnover RatioLossP/E (Static)2.71MShares6.750052wk High0.68P/B3.67MFloat Cap1.750152wk Low--Dividend TTM1.30MShs Float420.0000Historical High--Div YieldTTM6.58%Amplitude1.7500Historical Low2.8860Avg Price1Lot Size
Cyclerion Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -43.42%7.57M | -43.42%7.57M | -55.36%9.11M | -81.40%5.64M | -82.57%7.17M | -75.20%13.38M | -75.20%13.38M | -67.35%20.41M | -56.92%30.32M | -0.73%41.13M |
| -Cash and cash equivalents | -43.42%7.57M | -43.42%7.57M | -55.36%9.11M | -81.40%5.64M | -82.57%7.17M | -75.20%13.38M | -75.20%13.38M | -67.35%20.41M | -56.92%30.32M | -0.73%41.13M |
| Receivables | --0 | --0 | --0 | --0 | -57.71%96K | -4.00%96K | -4.00%96K | 43.67%227K | --227K | --227K |
| -Accounts receivable | --0 | --0 | --0 | --0 | -57.71%96K | -4.00%96K | -4.00%96K | 43.67%227K | --227K | --227K |
| Prepaid assets | -45.09%442K | -45.09%442K | 35.45%726K | 61.36%1.04M | -43.69%567K | -13.25%805K | -13.25%805K | -4.63%536K | -15.54%647K | -16.98%1.01M |
| Other current assets | -97.95%11K | -97.95%11K | -93.85%30K | -11.20%428K | 5.45%503K | 14.74%537K | 14.74%537K | 6.32%488K | -73.70%482K | -73.56%477K |
| Total current assets | -45.86%8.02M | -45.86%8.02M | -54.45%9.86M | -77.55%7.11M | -80.54%8.34M | -73.28%14.82M | -73.28%14.82M | -65.99%21.66M | -56.60%31.68M | -3.62%42.84M |
| Non current assets | ||||||||||
| Net PPE | --0 | --0 | --0 | -14.12%1.13M | -14.71%1.17M | -16.97%1.22M | -16.97%1.22M | -19.03%1.26M | 756.21%1.31M | -97.20%1.37M |
| -Gross PPE | -96.29%126K | -96.29%126K | --0 | -7.89%3.29M | -67.66%1.17M | -7.31%3.4M | -7.31%3.4M | -4.98%3.53M | 58.33%3.58M | -93.92%3.62M |
| -Accumulated depreciation | 94.22%-126K | 94.22%-126K | ---- | 4.28%-2.17M | ---- | 0.86%-2.18M | 0.86%-2.18M | -5.20%-2.27M | -7.60%-2.27M | 78.68%-2.25M |
| Investments and advances | --5.35M | --5.35M | --5.35M | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non current assets | ---- | ---- | ---- | -16.41%1.86M | -15.80%1.95M | -15.21%2.04M | -15.21%2.04M | -14.65%2.13M | -14.13%2.22M | -64.47%2.32M |
| Total non current assets | 64.16%5.35M | 64.16%5.35M | 57.49%5.35M | -15.56%2.98M | -15.40%3.12M | -15.88%3.26M | -15.88%3.26M | -16.33%3.4M | 28.84%3.53M | -93.36%3.69M |
| Total assets | -26.02%13.37M | -26.02%13.37M | -39.27%15.21M | -71.33%10.1M | -75.38%11.46M | -69.53%18.08M | -69.53%18.08M | -63.02%25.05M | -53.50%35.21M | -53.46%46.53M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -59.66%1.2M | -59.66%1.2M | -50.52%814K | -32.63%1.86M | 55.82%3.93M | 62.47%2.97M | 62.47%2.97M | 40.12%1.65M | 99.64%2.77M | 130.05%2.52M |
| -accounts payable | -59.66%1.2M | -59.66%1.2M | -50.52%814K | -32.63%1.86M | 55.82%3.93M | 62.47%2.97M | 62.47%2.97M | 40.12%1.65M | 99.64%2.77M | 130.05%2.52M |
| Current accrued expenses | -76.58%786K | -76.58%786K | -80.44%1.05M | -57.79%2.38M | -51.31%2.78M | -52.17%3.36M | -52.17%3.36M | 22.65%5.38M | 52.33%5.63M | 118.93%5.7M |
| Other current liabilities | 50.00%102K | 50.00%102K | -0.63%158K | -10.26%175K | -63.73%140K | -87.07%68K | -87.07%68K | -80.91%159K | -12.16%195K | 2.93%386K |
| Current liabilities | -72.65%2.09M | -72.65%2.09M | -72.55%2.34M | -49.79%4.95M | -20.65%7.53M | -31.20%7.63M | -31.20%7.63M | -24.89%8.53M | -6.26%9.85M | -29.52%9.49M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -72.65%2.09M | -72.65%2.09M | -72.55%2.34M | -49.79%4.95M | -20.65%7.53M | -31.20%7.63M | -31.20%7.63M | -24.89%8.53M | -6.26%9.85M | -81.58%9.49M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Preferred stock | --0 | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- |
| Retained earnings | -2.03%-264.42M | -2.03%-264.42M | -4.28%-262.72M | -11.95%-270.29M | -16.69%-266.11M | -20.49%-259.15M | -20.49%-259.15M | -23.32%-251.94M | -25.09%-241.44M | -28.97%-228.05M |
| Paid-in capital | 2.26%275.72M | 2.26%275.72M | 2.65%275.61M | 3.23%275.46M | 1.86%270.05M | 2.39%269.63M | 2.39%269.63M | 2.98%268.49M | 3.32%266.83M | 17.68%265.11M |
| Gains losses not affecting retained earnings | 40.00%-12K | 40.00%-12K | 35.71%-18K | 36.00%-16K | 20.83%-19K | 13.04%-20K | 13.04%-20K | -7.69%-28K | 3.85%-25K | 11.11%-24K |
| Total stockholders'equity | 8.00%11.29M | 8.00%11.29M | -22.10%12.87M | -79.69%5.15M | -89.40%3.93M | -78.34%10.45M | -78.34%10.45M | -70.70%16.52M | -61.12%25.36M | -23.54%37.03M |
| Total equity | 8.00%11.29M | 8.00%11.29M | -22.10%12.87M | -79.69%5.15M | -89.40%3.93M | -78.34%10.45M | -78.34%10.45M | -70.70%16.52M | -61.12%25.36M | -23.54%37.03M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg